An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)
Public ClinicalTrials.gov record NCT01598597. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or Metastatic Breast Cancer, Metastatic Colorectal Cancer, Metastatic Non-Squamous Non-Small Cell Lung Cancer, Recurrent Glioblastoma, or Metastatic Renal Cell Cancer Treated With Avastin
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This pilot, non-interventional, observational, Web-based, prospective cohort study is designed to collect self-reported safety and effectiveness and genetic data from subjects with locally recurrent breast cancer (BC) or metastatic breast cancer (MBC), metastatic colorectal cancer (MCRC), metastatic non-squamous non-small cell lung cancer (MNSCLC), recurrent glioblastoma (RGBM), or metastatic renal cell cancer (MRCC) in the United States who have been previously treated with Avastin (bevacizumab). The cohort will be composed of male and female subjects who have been diagnosed with locally recurrent BC or MBC, MCRC, MNSCLC, RGBM, or MRCC who have received treatment with bevacizumab in combination with chemotherapy, which started prior to or up to 31 December 2012. Participants will be self-referred to this study. They will be recruited online via a number of sources, including through the involvement of patient advocacy groups, social media tools, traditional media, physicians, and events to raise awareness of this study. After appropriate informed consent and authorization are obtained, data will be collected directly from subjects in an online survey. Participants will be contacted electronically to complete quarterly follow-up surveys. The follow-up period will be 1 year from responding to the baseline survey. DNA collection will be performed as part of this study. DNA will be extracted from saliva, which will be provided by the subject utilizing a collection kit sent to the participants for at-home use.
Study identification
- NCT ID
- NCT01598597
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 276 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2012 (Type not available)
- Primary completion
- Nov 2014 (Actual)
- Completion
- Nov 2014 (Actual)
- Last update posted
- May 8, 2015
2012 – 2014
United States locations
- U.S. sites
- 50
- U.S. states
- 50
- U.S. cities
- 50
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Many Locations | Alabama | — | — |
| Not listed | Many Locations | Alaska | — | — |
| Not listed | Many Locations | Arizona | — | — |
| Not listed | Many Locations | Arkansas | — | — |
| Not listed | Many Locations | California | — | — |
| Not listed | Many Locations | Colorado | — | — |
| Not listed | Many Locations | Connecticut | — | — |
| Not listed | Many Locations | Delaware | — | — |
| Not listed | Many Locations | Florida | — | — |
| Not listed | Many Locations | Georgia | — | — |
| Not listed | Many Locations | Hawaii | — | — |
| Not listed | Many Locations | Idaho | — | — |
| Not listed | Many Locations | Illinois | — | — |
| Not listed | Many Locations | Indiana | — | — |
| Not listed | Many Locations | Iowa | — | — |
| Not listed | Many Locations | Kansas | — | — |
| Not listed | Many Locations | Kentucky | — | — |
| Not listed | Many Locations | Louisiana | — | — |
| Not listed | Many Locations | Maine | — | — |
| Not listed | Many Locations | Maryland | — | — |
| Not listed | Many Locations | Massachusetts | — | — |
| Not listed | Many Locations | Michigan | — | — |
| Not listed | Many Locations | Minnesota | — | — |
| Not listed | Many Locations | Mississippi | — | — |
| Not listed | Many Locations | Missouri | — | — |
| Not listed | Many Locations | Montana | — | — |
| Not listed | Many Locations | Nebraska | — | — |
| Not listed | Many Locations | Nevada | — | — |
| Not listed | Many Locations | New Hampshire | — | — |
| Not listed | Many Locations | New Jersey | — | — |
| Not listed | Many Locations | New Mexico | — | — |
| Not listed | Many Locations | New York | — | — |
| Not listed | Many Locations | North Carolina | — | — |
| Not listed | Many Locations | North Dakota | — | — |
| Not listed | Many Locations | Ohio | — | — |
| Not listed | Many Locations | Oklahoma | — | — |
| Not listed | Many Locations | Oregon | — | — |
| Not listed | Many Locations | Pennsylvania | — | — |
| Not listed | Many Locations | Rhode Island | — | — |
| Not listed | Many Locations | South Carolina | — | — |
| Not listed | Many Locations | South Dakota | — | — |
| Not listed | Many Locations | Tennessee | — | — |
| Not listed | Many Locations | Texas | — | — |
| Not listed | Many Locations | Utah | — | — |
| Not listed | Many Locations | Vermont | — | — |
| Not listed | Many Locations | Virginia | — | — |
| Not listed | Many Locations | Washington | — | — |
| Not listed | Many Locations | West Virginia | — | — |
| Not listed | Many Locations | Wisconsin | — | — |
| Not listed | Many Locations | Wyoming | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01598597, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 8, 2015 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01598597 live on ClinicalTrials.gov.